IONS

IONIS PHARMACEUTICALS INC

IONS·462222100·US·Common Stock·Healthcare - Biotechnology-13D/G

IONS (IONIS PHARMACEUTICALS INC) is held by 221 institutional investors as of Q1 2026. Largest holders: FMR LLC ($1.8B), Capital World Investors ($1.6B), BlackRock, Inc. ($784.1M). Net institutional sentiment: Mixed.

221
Holders
(19 Elite)
$10.9B
Total Value
57% (220)
Consensus
125 buying - 95 selling
13F: Insider & Congress:
IONS

Smart Money Verdict

View all
Held by 221 funds
19 elite

Who's Trading

ActivistTRT. Rowe Price Investment Management, Inc.3.7%May 15, 2026
ActivistCapital World InvestorsCapital World Investors12.8%May 14, 2026
InsiderLJLOSCALZO JOSEPHExercise 16K shMay 4, 2026
InsiderLJLOSCALZO JOSEPHExercise 12K shMay 4, 2026
InsiderLJLOSCALZO JOSEPHExercise 16K shMay 4, 2026
InsiderLJLOSCALZO JOSEPHExercise 10K shMay 4, 2026
InsiderLJLOSCALZO JOSEPHExercise 12K shMay 4, 2026
InsiderLJLOSCALZO JOSEPHSell $4.5MMay 4, 2026
InsiderLJLOSCALZO JOSEPHExercise 11K shMay 4, 2026
InsiderLJLOSCALZO JOSEPHSell $1.3MMay 4, 2026

Top Holders

Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
24.6M(+2.0%)$1.8B0.1%+55.43%
33
Increased
21.2M(+18.0%)$1.6B0.2%+2.35%
45
Decreased
10.4M(-1.9%)$784.1M0.0%+58.22%
0
New
7.8M$586.4M0.0%-28.10%
44
New
7.1M$534.5M0.0%-28.10%
43
Increased
6.4M(+2.1%)$480M0.1%+20.74%
32
Increased
5.9M(+120.3%)$439.8M0.4%-16.89%
60
Increased
4M(+26.5%)$305.2M0.0%+1.42%
38
Increased
4M(+0.5%)$300M0.0%+18.60%
31
Increased
3.8M(+239.8%)$285.5M0.1%-18.02%
50
Increased
3M(+1.3%)$227.2M0.0%+28.61%
31
Increased
2.4M(+2.5%)$171.4M0.0%-19.95%
31
Increased
2.1M(+74.2%)$154.6M0.2%-17.74%
55
Increased
2M(+14.3%)$153.8M0.9%-24.41%
49
Increased
1.7M(+98.6%)$127.6M0.0%-3.18%
48
Increased
1.7M(+2.9%)$124.9M0.1%-4.48%
31
Increased
1.6M(+2.7%)$118.9M0.0%+21.91%
31
Increased
1.6M(+19.2%)$118.3M0.0%-28.20%
36
Increased
1.5M(+6.3%)$110.8M0.0%+2.73%
32
Increased
1.4M(+1.2%)$107.1M0.1%-0.29%
36

Showing 1-20 of 236

1 / 12
IONSIONSIONIS PHARMACEUTICALS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used